Vuzix Corporation
Loading financial statements...
Financial statements
data from SEC XBRL filings. Values are as-reported; restatements supersede originals. Values reported in .
| Line item |
|---|
| Period ending |
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations
You should read the following discussion and analysis of financial condition and results of operations in conjunction with the financial statements and related notes appearing elsewhere in this quarterly report and in our Annual Report on Form 10-K for the year ended December 31, 2025.
As used in this report, unless otherwise indicated, the terms “Company,” “Vuzix”, “management,” “we,” “our,” and “us” refer to Vuzix Corporation.
Critical Accounting Policies and Significant Developments and Estimates
The discussion and analysis of our financial condition and results of operations is based upon our unaudited consolidated financial statements and related notes appearing elsewhere in this quarterly report. The preparation of these statements in conformity with GAAP requires the appropriate application of certain accounting policies, many of which require us to make estimates and assumptions about future events and their impact on amounts reported in our consolidated financial statements, including the statement of operations, balance sheet, cash flow and related notes. We continually evaluate our estimates used in the preparation of our financial statements, including those related to revenue recognition, allowance for credit losses, inventories, warranty reserves, product warranty, carrying value of long-lived assets, fair value measurement of financial instruments, valuation of stock compensation awards, and income taxes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not apparent from other sources. Since future events and their impact cannot be determined with certainty, the actual results will inevitably differ from our estimates. Such differences could be material to the consolidated financial statements.
We believe that our application of accounting policies, and the estimates inherently required therein, are reasonable. We periodically re-evaluate these accounting policies and estimates and make adjustments when facts and circumstances dictate. Historically, we have found our application of accounting policies to be appropriate, and actual results have not differed materially from those determined using such necessary estimates.
Management believes certain factors and trends are important in understanding our financial performance. The critical accounting policies, judgments and estimates we believe have the most significant effect on our consolidated financial statements are:
| ● | Valuation of inventories; |
| ● | Going concern; |
| ● | Evaluation of liabilities to equity and derivatives; |
| ● | Variable interest entities; |
| ● | Investments in equity securities; |
| ● | Carrying value of long-lived assets, goodwill and other intangible assets; |
| ● | Software development costs; |
19
| ● | Revenue recognition; |
| ● | Product warranty; |
| ● | Stock-based compensation; and |
| ● | Income taxes. |
Our accounting policies are more fully described in the notes to our consolidated financial statements included in this quarterly report and in our Annual Report on Form 10-K for the year ended December 31, 2025. There have been no significant changes in our accounting policies for the three months ended March 31, 2026.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, an effect on our financial condition, financial statements, revenues or expenses.
Business Matters
We are engaged in the design, manufacture, marketing and sale of augmented reality wearable display devices also referred to as head mounted displays (or HMDs, but also known as near-eye displays), in the form of Smart Glasses, AI powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Our wearable display devices are worn like eyeglasses or attach to a head worn mount. These devices typically include cameras, sensors, and a computer that enable the user to view, record and interact with video and digital content, such as computer data, the Internet, social media or entertainment applications. Our wearable display products integrate microdisplay technology with our advanced optics to produce compact high-resolution display engines, less than half an inch diagonally, which when viewed through our Smart Glasses products create virtual images that appear comparable in size to that of a computer monitor or a large-screen television.
With respect to our Smart Glasses and AI/AR products, we are focused on the enterprise, defense, medical, security, and select consumer applications. All of the mobile display and mobile electronics markets in which we compete have been subject to rapid technological change over the last decade including the rapid adoption of tablets, larger screen sizes, and display resolutions, along with declining prices on mobile phones and other computing devices, and as a result we must continue to improve our products’ performance and lower our costs. We believe our technology, intellectual property portfolio and position in the marketplace give us a leadership position in AI/AR and Smart Glasses products, waveguide optics, microLEDs and display engine technology.
Recent Accounting Pronouncements
See Note 1 to the Unaudited Consolidated Financial Statements.
20
Results of Operations
Comparison of Three Months Ended March 31, 2026 and 2025
The following table compares the Company’s consolidated statements of operations data for the three months ended March 31, 2026 and 2025:
| | | | | | | | | | | | |
| | Three Months Ended March 31, | | |||||||||
| | | | | | | | Dollar | | % Increase |
| |
| | 2026 | | 2025 | | Change | | (Decrease) |
| |||
| | | | | | | | | | | | |
Sales: |
| | |
| | |
| | |
| | |
Sales of Products | | $ | 1,042,388 | | $ | 1,324,073 | | $ | (281,685) |
| (21) | % |
Sales of Engineering Services | |
| 348,936 | |
| 256,868 | |
| 92,068 |
| 36 | % |
| | | | | | | | | | | | |
Total Sales | |
| 1,391,324 | |
| 1,580,941 | |
| (189,617) |
| (12) | % |
| | | | | | | | | | | | |
Cost of Sales: | |
| | |
| | |
| |
| | |
Cost of Sales - Products Sold | |
| 1,472,172 | |
| 1,610,730 | |
| (138,558) |
| (9) | % |
Cost of Sales - Depreciation and Amortization | |
| 82,741 | |
| 176,869 | |
| (94,128) |
| (53) | % |
Cost of Sales - Engineering Services | |
| 214,322 | |
| 58,460 | |
| 155,862 |
| 267 | % |
| | | | | | | | | | | | |
Total Cost of Sales | |
| 1,769,235 | |
| 1,846,059 | |
| (76,824) |
| (4) | % |
| | | | | | | | | | | | |
Gross Loss | |
| (377,911) | |
| (265,118) | |
| (112,793) |
| 43 | % |
Gross Loss % | |
| (27) | % |
| (17) | % |
| |
| | |
| | | | | | | | | | | | |
Operating Expenses: | |
| | |
| | |
| |
| | |
Research and Development | |
| 3,028,355 | |
| 2,605,840 | |
| 422,515 |
| 16 | % |
Selling and Marketing | |
| 1,550,866 | |
| 1,537,466 | |
| 13,400 |
| 1 | % |
General and Administrative | |
| 2,133,942 | |
| 3,960,984 | |
| (1,827,042) |
| (46) | % |
Depreciation and Amortization | |
| 115,017 | |
| 405,011 | |
| (289,994) |
| (72) | % |
| | | | | | | | | | | | |
Loss from Operations | |
| (7,206,091) | |
| (8,774,419) | |
| 1,568,328 |
| (18) | % |
| | | | | | | | | | | | |
Other Income (Expense): | |
| | |
| | |
| |
| | |
Investment Income | |
| 168,401 | |
| 168,480 | |
| (79) |
| (0) | % |
Other Taxes | |
| (16,133) | |
| (18,400) | |
| 2,267 |
| (12) | % |
Foreign Exchange Loss | |
| (17,501) | |
| (13,287) | |
| (4,214) |
| 32 | % |
| | | | | | | | | | | | |
Total Other Income, Net | |
| 134,767 | |
| 136,793 | |
| (2,026) |
| (1) | % |
| | | | | | | | | | | | |
Net Loss | | $ | (7,071,324) | | $ | (8,637,626) | | $ | 1,566,302 |
| (18) | % |
Sales. There was a decrease in total sales for the three months ended March 31, 2026, compared to the same period in 2025 of $189,617, or 12%. The following table reflects the major components of our sales:
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | % of | | Three Months Ended | | % of | | Dollar | | % Increase | | |||
| | March 31, 2026 | | Total Sales | | March 31, 2025 | | Total Sales | | Change | | (Decrease) | | |||
Sales of Products | | $ | 1,042,388 |
| 75 | % | $ | 1,324,073 |
| 84 | % | $ | (281,685) |
| (21) | % |
Sales of Engineering Services | |
| 348,936 |
| 25 | % |
| 256,868 |
| 16 | % |
| 92,068 |
| 36 | % |
Total Sales | | $ | 1,391,324 |
| 100 | % | $ | 1,580,941 |
| 100 | % | $ | (189,617) |
| (12) | % |
21
Sales of products decreased by 21% for the three months ended March 31, 2026, compared to the same period in 2025.
Sales of engineering services and OEM products for the three months ended March 31, 2026, were $348,936 compared to $256,868 in the comparable 2025 period, an increase of 36%.
Cost of Sales and Gross Loss. Cost of product revenues and engineering services are comprised of materials, components, labor, warranty costs, freight costs, manufacturing overhead, software royalties, the depreciation for our tooling and manufacturing equipment, and amortization of software development costs related to the production of our products and rendering of engineering services. The following table reflects the components of our cost of sales:
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | % of | | Three Months Ended | | % of | | Dollar | | % Increase | | |||
| | March 31, 2026 | | Total Sales | | March 31, 2025 | | Total Sales | | Change | | (Decrease) | | |||
Product Cost of Sales | | $ | 859,444 |
| 62 | % | $ | 1,026,615 |
| 65 | % | $ | (167,171) |
| (16) | % |
Manufacturing Overhead - Unapplied | |
| 612,728 |
| 44 | % |
| 584,115 |
| 37 | % |
| 28,613 |
| 5 | % |
Depreciation and Amortization | |
| 82,741 |
| 6 | % |
| 176,869 |
| 11 | % |
| (94,128) |
| (53) | % |
Engineering Services Cost of Sales | |
| 214,322 |
| 15 | % |
| 58,460 |
| 4 | % |
| 155,862 |
| 267 | % |
| | | | | | | | | | | ||||||
Recent insider activity
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | Harned Timothy Heydenreich | Director | Sell | -10,000 | $4.73 | -$47,300 |
| 2026-03-04 | Parkinson Christopher Iain | See remarks | Sell | -11,663 | $2.69 | -$31,368 |
Source: SEC Form 4 filings.
Next expected filings
- ~2026-08-14 10-Q expected by 2026-08-18 (in 81 days)
- ~2026-11-13 10-Q expected by 2026-11-17 (in 172 days)
- ~2027-05-14 10-Q expected by 2027-05-18 (in 354 days)
Predicted from historical filing cadence; not an SEC commitment.
Recent SEC filings
- 2026-05-15 8-K Earnings Release; Financial Statements and Exhibits
- 2026-05-14 10-Q Quarterly Report
- 2026-04-30 8-K Officer/Director Change
- 2026-04-28 DEF 14A Proxy Statement
- 2026-04-24 8-K Officer/Director Change
- 2026-03-13 8-K Earnings Release; Financial Statements and Exhibits
- 2026-03-12 10-K Annual Report
- 2025-12-10 S-3/A S-3/A
- 2025-11-14 8-K Earnings Release; Financial Statements and Exhibits
- 2025-11-13 10-Q Quarterly Report
- 2025-10-08 S-3 Registration Statement
- 2025-09-23 8-K Unregistered Equity Sale
- 2025-09-08 8-K Material Agreement Entered; Financial Statements and Exhibits
- 2025-08-27 8-K Changes in Auditor; Financial Statements and Exhibits
- 2025-08-15 8-K Earnings Release; Financial Statements and Exhibits